Gel and Capillary Electrophoresis Compared for Human Proteins
|
By LabMedica International staff writers Posted on 12 May 2021 |

Image: The Capillarys 3 TERA is an automated analyzer based on capillary zone electrophoresis and UV detection for the quantitative analysis of Hba1c, proteins (serum and urine), immunotyping (serum and urine), and carbohydrate deficient transferrin (Photo courtesy of Sebia)
The electrophoresis of serum proteins remains a laboratory cornerstone for the diagnosis and monitoring of patients with plasma cell disorders, such as monoclonal gammopathy of undetermined significance, multiple myeloma, Waldenström macroglobulinemia, and AL amyloidosis.
Gel electrophoresis remains the method used by most clinical laboratories in the USA. However usage of gel electrophoresis is gradually decreasing while that of capillary electrophoresis is increasing. More recently, analysis of liquid media by capillary electrophoresis was developed and applied to the analysis of serum proteins for clinical purposes.
Laboratory Immunologists at The Johns Hopkins School of Medicine (Baltimore, MD, USA) tested all serum samples analyzed by the immunology laboratory over the course of eight days for routine clinical purposes during the months of October and November 2019, totaling 304 sera. There were 160 females (62 ± 16 years, range 19 -95) and 144 males (65 ± 14 years, range 23-97), with no significant difference in age according to sex.
Sera were first ran using the system currently in use, which consists of a thin-layer agarose gel, HYDRAGEL 30 Protein (E) (Sebia, Lisses, France) and the Sebia Hydrasys 2 semi-automated analyzer. Sera were then assayed on the Sebia Capillarys III TERA automated analyzer using CAPI 3 Protein (E) reagents. Serum immunofixation electrophoresis (SIFE) was performed in 214 of the total 304 sera because already ordered by the provider for most cases. Sera were pre-diluted according to the immunoglobulin G, A, and M concentrations, and then ran on the immunofixation system currently in use, which consists of a thin-layer agarose gel (HYDRAGEL IF 2/4, from Sebia) and the Hydrasys 2 semi-automated analyzer.
The scientists reported that Gel and capillary estimated the concentration of albumin, gamma region, and M-spikes nearly perfectly, and that of beta, alpha-2, and alpha-1 regions with excellent correlation. The two systems classified concordantly 268 of 304 sera (88% agreement) as having no, one, or two M-spikes, but differed in the remaining 36 sera (12%). Gel electrophoresis correctly identified M-spikes in 82 of 112 sera that were shown to have monoclonal band(s) by immunofixation (73% sensitivity), and correctly did not reveal M-spikes in 97/102 sera that had no immunofixation bands (95% specificity). Capillary achieved slightly higher sensitivity (85/112, 76%) and slightly lower specificity (94/102, 92%), but the two areas under the ROC curves were nearly identical at 0.84.
The authors concluded that Gel and capillary electrophoresis systems perform similarly to estimate the concentration of serum protein fractions and detect M-spikes. The Capillarys system has the disadvantages of a higher equipment cost and requiring a greater sample volume. On the other hand, Capillarys requires less involvement of laboratory technicians, offers a faster turn-around time, identifies the specimens they are being analyzed, does not depend upon the chemicals needed to stain and destain the gels, and is more amenable to remote reporting. The study was published on April 29, 2021 in the journal Practical Laboratory Medicine.
Related Links:
The Johns Hopkins School of Medicine
Sebia
Gel electrophoresis remains the method used by most clinical laboratories in the USA. However usage of gel electrophoresis is gradually decreasing while that of capillary electrophoresis is increasing. More recently, analysis of liquid media by capillary electrophoresis was developed and applied to the analysis of serum proteins for clinical purposes.
Laboratory Immunologists at The Johns Hopkins School of Medicine (Baltimore, MD, USA) tested all serum samples analyzed by the immunology laboratory over the course of eight days for routine clinical purposes during the months of October and November 2019, totaling 304 sera. There were 160 females (62 ± 16 years, range 19 -95) and 144 males (65 ± 14 years, range 23-97), with no significant difference in age according to sex.
Sera were first ran using the system currently in use, which consists of a thin-layer agarose gel, HYDRAGEL 30 Protein (E) (Sebia, Lisses, France) and the Sebia Hydrasys 2 semi-automated analyzer. Sera were then assayed on the Sebia Capillarys III TERA automated analyzer using CAPI 3 Protein (E) reagents. Serum immunofixation electrophoresis (SIFE) was performed in 214 of the total 304 sera because already ordered by the provider for most cases. Sera were pre-diluted according to the immunoglobulin G, A, and M concentrations, and then ran on the immunofixation system currently in use, which consists of a thin-layer agarose gel (HYDRAGEL IF 2/4, from Sebia) and the Hydrasys 2 semi-automated analyzer.
The scientists reported that Gel and capillary estimated the concentration of albumin, gamma region, and M-spikes nearly perfectly, and that of beta, alpha-2, and alpha-1 regions with excellent correlation. The two systems classified concordantly 268 of 304 sera (88% agreement) as having no, one, or two M-spikes, but differed in the remaining 36 sera (12%). Gel electrophoresis correctly identified M-spikes in 82 of 112 sera that were shown to have monoclonal band(s) by immunofixation (73% sensitivity), and correctly did not reveal M-spikes in 97/102 sera that had no immunofixation bands (95% specificity). Capillary achieved slightly higher sensitivity (85/112, 76%) and slightly lower specificity (94/102, 92%), but the two areas under the ROC curves were nearly identical at 0.84.
The authors concluded that Gel and capillary electrophoresis systems perform similarly to estimate the concentration of serum protein fractions and detect M-spikes. The Capillarys system has the disadvantages of a higher equipment cost and requiring a greater sample volume. On the other hand, Capillarys requires less involvement of laboratory technicians, offers a faster turn-around time, identifies the specimens they are being analyzed, does not depend upon the chemicals needed to stain and destain the gels, and is more amenable to remote reporting. The study was published on April 29, 2021 in the journal Practical Laboratory Medicine.
Related Links:
The Johns Hopkins School of Medicine
Sebia
Latest Immunology News
- Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
- Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
- Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
- Blood Test Could Identify Colon Cancer Patients to Benefit from NSAIDs
- Blood Test Could Detect Adverse Immunotherapy Effects
- Routine Blood Test Can Predict Who Benefits Most from CAR T-Cell Therapy
- New Test Distinguishes Vaccine-Induced False Positives from Active HIV Infection
- Gene Signature Test Predicts Response to Key Breast Cancer Treatment
- Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
- Blood-Based Liquid Biopsy Model Analyzes Immunotherapy Effectiveness
- Signature Genes Predict T-Cell Expansion in Cancer Immunotherapy
- Molecular Microscope Diagnostic System Assesses Lung Transplant Rejection
- Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer
- Luminescent Probe Measures Immune Cell Activity in Real Time
- Blood-Based Immune Cell Signatures Could Guide Treatment Decisions for Critically Ill Patients
- Novel Tool Predicts Most Effective Multiple Sclerosis Medication for Patients
Channels
Clinical Chemistry
view channel
Rapid Blood Testing Method Aids Safer Decision-Making in Drug-Related Emergencies
Acute recreational drug toxicity is a frequent reason for emergency department visits, yet clinicians rarely have access to confirmatory toxicology results in real time. Instead, treatment decisions are... Read more
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read moreMolecular Diagnostics
view channel
Genetic Test Could Improve Early Detection of Prostate Cancer
Prostate cancer is the second-leading cause of cancer deaths among men in the United States and remains a major health burden. Current screening with prostate-specific antigen (PSA) blood tests can sometimes... Read more
Bone Molecular Maps to Transform Early Osteoarthritis Detection
Osteoarthritis affects more than 500 million people worldwide and is a major cause of pain, disability, and reduced quality of life. By the time it is diagnosed through symptoms and visible cartilage loss,... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreMicrobiology
view channel
CRISPR-Based Technology Neutralizes Antibiotic-Resistant Bacteria
Antibiotic resistance has accelerated into a global health crisis, with projections estimating more than 10 million deaths per year by 2050 as drug-resistant “superbugs” continue to spread.... Read more
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read morePathology
view channel
AI-Powered Microscope Diagnoses Malaria in Blood Smears Within Minutes
Malaria remains one of the world’s deadliest infectious diseases, killing hundreds of thousands each year, mostly in under-resourced regions where laboratory infrastructure is limited. Diagnosis still... Read more
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channel
WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories
WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read moreNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more







